Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    TScan Therapeutics Inc.

    NASDAQ: TCRX · Real-Time Price · USD
    1.70
    -0.08 (-4.49%)
    At close: Jun 05, 2025, 12:46 PM

    TScan Therapeutics Revenue

    TScan Therapeutics reported an annual revenue of $2.82M, reflecting a -86.62% growth. For the quarter ending March 31, 2025, TScan Therapeutics generated $2.17M in revenue.
    Revenue (ttm)
    $2.82M
    Revenue Growth
    -86.62%
    Price / Sales Ratio
    120.9
    Revenue / Employee
    $14.08K
    Employees
    200
    Market Cap
    96.2M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist